These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16957335)

  • 1. Design of miniproteins by the transfer of active sites onto small-size scaffolds.
    Stricher F; Martin L; Vita C
    Methods Mol Biol; 2006; 340():113-49. PubMed ID: 16957335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel miniproteins engineered by the transfer of active sites to small natural scaffolds.
    Vita C; Vizzavona J; Drakopoulou E; Zinn-Justin S; Gilquin B; Ménez A
    Biopolymers; 1998; 47(1):93-100. PubMed ID: 9692330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
    Li H; Song H; Heredia A; Le N; Redfield R; Lewis GK; Wang LX
    Bioconjug Chem; 2004; 15(4):783-9. PubMed ID: 15264865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common pharmacophoric footprint for AIDS vaccine design.
    Pisterer C; Mihailescu D; Smith JC; Reed J
    J Med Chem; 2004 Jul; 47(15):3723-9. PubMed ID: 15239651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth.
    Huang CC; Stricher F; Martin L; Decker JM; Majeed S; Barthe P; Hendrickson WA; Robinson J; Roumestand C; Sodroski J; Wyatt R; Shaw GM; Vita C; Kwong PD
    Structure; 2005 May; 13(5):755-68. PubMed ID: 15893666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput fluorescence polarization assay specific to the CD4 binding site of HIV-1 glycoproteins based on a fluorescein-labelled CD4 mimic.
    Stricher F; Martin L; Barthe P; Pogenberg V; Mechulam A; Menez A; Roumestand C; Veas F; Royer C; Vita C
    Biochem J; 2005 Aug; 390(Pt 1):29-39. PubMed ID: 15836438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amino acid residues of a designed ankyrin repeat protein potentially involved in intermolecular interactions with CD4: analysis by molecular dynamics simulations.
    Nimmanpipug P; Khampa C; Lee VS; Nangola S; Tayapiwatana C
    J Mol Graph Model; 2011 Nov; 31():65-75. PubMed ID: 21962990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
    Kolmar H
    FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
    Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional design of potential inhibitors of human immunodeficiency virus (HIV) binding to CD4+ target cells: a molecular model of gp120 predicts ligand binding.
    Gabriel JL; Mitchell WM
    Drug Des Discov; 1996 Oct; 14(2):103-14. PubMed ID: 9010617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the V3 loop involved in HIV binding to CD4?
    Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
    Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the coevolutionary patterns operating within the env gene of the HIV-1 group M subtypes.
    Travers SA; Tully DC; McCormack GP; Fares MA
    Mol Biol Evol; 2007 Dec; 24(12):2787-801. PubMed ID: 17921487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
    Yang J; Liu CQ
    Acta Pharmacol Sin; 2000 Jan; 21(1):29-34. PubMed ID: 11263244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of stabilized derivatives of human CD4D12 and CD4D1.
    Saha P; Barua B; Bhattacharyya S; Balamurali MM; Schief WR; Baker D; Varadarajan R
    Biochemistry; 2011 Sep; 50(37):7891-900. PubMed ID: 21827143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-HIV activity of trivalent CD4-mimetic miniproteins.
    Li H; Guan Y; Szczepanska A; Moreno-Vargas AJ; Carmona AT; Robina I; Lewis GK; Wang LX
    Bioorg Med Chem; 2007 Jun; 15(12):4220-8. PubMed ID: 17412600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT; Meyer B
    Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular dynamics study of the proposed beta-hairpin form of the switch domain from HIV1 gp120 alone and complexed with an inhibitor of CD4 binding.
    Graf von Stosch A; von der Lieth CW; Reed J
    Proteins; 1999 Feb; 34(2):197-205. PubMed ID: 10022355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.
    Saphire EO; Parren PW; Pantophlet R; Zwick MB; Morris GM; Rudd PM; Dwek RA; Stanfield RL; Burton DR; Wilson IA
    Science; 2001 Aug; 293(5532):1155-9. PubMed ID: 11498595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.